Generic Portal

— Research Explorer

Co-stimulatory versus cell death aspects of agonistic cd40 monoclonal antibody selicrelumab in chronic lymphocytic leukemia

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.3390/cancers13123084
Final published version

Raquel Delgado
Karoline Kielbassa
Johanna ter Burg
Christian Klein
Christine Trumpfheller
Koen de Heer
Arnon P. Kater
Eric Eldering

Original language	English
Article number	3084
Journal	Cancers
Volume	13
Issue number	12
DOIs	https://doi.org/10.3390/cancers13123084
Publication status	Published - 2 Jun 2021

Research areas

ACD20 immunotherapy, CD40 activation, CLL, Venetoclax

ID: 18757940